List view / Grid view
21 July 2015 | By Victoria White
Emergent BioSolutions has been awarded a BARDA contract valued at $19.7 million to develop and manufacture three Ebola monoclonal antibodies...
21 July 2015 | By
Researchers have now shown that a “messenger molecule” produced by P. aeruginosa encourage bacteria to colonise catheters, forming a biofilm...
21 July 2015 | By Victoria White
Symic Biomedical has selected SBCV-030 as its vascular clinical candidate. SBCV-030 inhibits the scarring response that occurs when a vessel is injured...
21 July 2015 | By Victoria White
Examining post-mortem tissue from the brains of people with Alzheimer's disease, researchers identified iron-containing microglia in the hippocampus...
20 July 2015 | By Victoria White
TRV 101 has successfully demonstrated significant reduction in both amyloid beta and tau toxic aggregates in mouse models of Alzheimer’s Disease...
20 July 2015 | By
Using existing drugs to restore basic biological processes in human cells, researchers may have devised effective treatments for mitochondrial diseases...
20 July 2015 | By Victoria White
Certain patients with type 2 diabetes may have specific genetic risk factors that put them at higher risk for developing Alzheimer’s disease...
20 July 2015 | By Victoria White
Lower levels of cholesterol in certain immune cells may help explain why some HIV-infected people are able to naturally control disease progression...
20 July 2015 | By Victoria White
Cellecta has announced the receipt of Phase I SBIR grant funds from the NIH to further its CRISPR-mediated genome-editing library...
17 July 2015 | By Oxford Global
In the run up to our 2015 Next Generation Sequencing Congress, Single Cell Congress & Genome Editing Congress we spoke with Jacqueline Boultwood, University of Oxford...
17 July 2015 | By Biosimilars and Biobetters
This year's conference will address recent regulatory updates, pharmacovigilance of biosimilars, patent litigation, market access & global market developments...
17 July 2015 | By Victoria White
Scientists have found that existing anti-malaria drugs, Chloroquine and Amodiaquine, could be a potential treatment for Parkinson's disease...
16 July 2015 | By Victoria White
Novogen has received notification FDA that its chemotherapy candidate drug, Anisina, has been granted Orphan Drug Designation for neuroblastoma...
16 July 2015 | By Victoria White
Achaogen has been awarded a $4.5 million contract for the discovery and development of LpxC inhibitors for the treatment of bacterial infections...
16 July 2015 | By Victoria White
Researchers have discovered two chemical compounds that effectively stop the growth of brain cancer cells and breast tumours by inhibiting the Stat3 protein...
